Seven Mile Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $317K | Buy |
712
+3
| +0.4% | +$1.34K | 0.19% | 112 |
|
|
2025
Q1 | $344K | Buy |
709
+23
| +3% | +$11.2K | 0.23% | 95 |
|
|
2024
Q4 | $276K | Buy |
686
+9
| +1% | +$3.62K | 0.18% | 109 |
|
|
2024
Q3 | $315K | Buy |
677
+35
| +5% | +$16.3K | 0.21% | 97 |
|
|
2024
Q2 | $301K | Buy |
642
+33
| +5% | +$15.5K | 0.22% | 91 |
|
|
2024
Q1 | $255K | Buy |
609
+5
| +0.8% | +$2.09K | 0.19% | 116 |
|
|
2023
Q4 | $246K | Sell |
604
-1
| -0.2% | -$407 | 0.21% | 109 |
|
|
2023
Q3 | $210K | Buy |
605
+7
| +1% | +$2.43K | 0.22% | 109 |
|
|
2023
Q2 | $210K | Buy |
+598
| New | +$210K | 0.25% | 97 |
|